Orbus Therapeutics, Inc. — Form D
Orbus Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-11. The offering totals $27.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-11
- Form: D
- Accession: 0001288320-20-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $27.0M
- Amount sold: $10.0M
- Remaining: $17.0M
- Investors: 1
- Date of first sale: 2020-07-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-372998
Issuer
- Name: Orbus Therapeutics, Inc.
- CIK: 0001650743
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 2479 EAST BAYSHORE ROAD, PALO ALTO, CA, 94303
- Phone: (650) 656-9421
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Patrick D Enright | Director | Palo Alto, CA |
| Elisha (Terry) D Gould | Director | Palo Alto, CA |
| Jason D Levin | Director | Palo Alto, CA |
| Ernest D Mario | Director | Palo Alto, CA |
| Robert M Myers | Director | Palo Alto, CA |
| Kurt D von Emster | Director | Palo Alto, CA |
| Michael D Wasserman | Director | Palo Alto, CA |
| Jason D Levin | Executive Officer | Palo Alto, CA |
| Robert M Myers | Executive Officer | Palo Alto, CA |
Other filings by this issuer (3)
More